Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer at high risk of disease recurrence (D-CARE): An international, placebo-controlled, randomized, double-blind phase III clinical trial.
Paul E. Goss
No relevant relationships to disclose
Carlos H. Barrios
Consultant or Advisory Role - Novartis
Arlene Chan
No relevant relationships to disclose
Dianne M. Finkelstein
Consultant or Advisory Role - Amgen
Hiroji Iwata
Consultant or Advisory Role - Daiichi Sankyo
Miguel Martin
Consultant or Advisory Role - Amgen; Roche
Ada Braun
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Beiying Ding
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Tapan Maniar
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Robert E. Coleman
Consultant or Advisory Role - Bayer
Honoraria - Amgen; Bayer
Expert Testimony - Novartis